Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 7/2017

01-07-2017 | Letter to the Editor

Response to “Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial”

Author: David Hawkes

Published in: Clinical Rheumatology | Issue 7/2017

Login to get access

Excerpt

To the Editor, …
Literature
1.
Martinez-Lavin M (2017) Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial. Clin Rheumatol. doi:10.​1007/​s10067-017-3575-z
2.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A, Broad Spectrum HPVVS (2015) A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372(8):711–723. doi:10.​1056/​NEJMoa1405044 CrossRefPubMed
3.
4.
Metadata
Title
Response to “Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial”
Author
David Hawkes
Publication date
01-07-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3609-6

Other articles of this Issue 7/2017

Clinical Rheumatology 7/2017 Go to the issue

Case Based Review

Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature

Review Article

IL-6 blockade in the management of non-infectious uveitis

Original Article

The added value of synovial fluid centrifugation for monosodium urate and calcium pyrophosphate crystal detection

Original Article

Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study

Original Article

Clinical effectiveness and safety of leflunomide in inflammatory arthritis: a report from the RAPPORT database with supporting patient survey

Original Article

An evidence-based walking program among older people with knee osteoarthritis: the PEP (participant exercise preference) pilot randomized controlled trial

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits